PROCYON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PROCYON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $4.98M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $4.69M | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $4.84M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $4.72M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $4.33M | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $4.19M | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $4.02M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $4.01M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $3.45M | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $2.77M | Sep 28, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $3.89M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $3.57M | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $3.49M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $3.39M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $3.20M | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $3.05M | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $2.94M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $2.75M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $2.42M | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $1.96M | Sep 28, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $38.0K | Oct 25, 2024 |
| FY2024 | Mar 31, 2024 | ($102.8K) | Oct 25, 2024 |
| FY2024 | Dec 31, 2023 | ($242.5K) | Oct 25, 2024 |
| FY2024 | Sep 30, 2023 | ($33.9K) | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $7.5K | Oct 25, 2024 |
| FY2024 | Mar 31, 2023 | ($29.5K) | Oct 25, 2024 |
| FY2024 | Dec 31, 2022 | ($20.1K) | Oct 25, 2024 |
| FY2024 | Sep 30, 2022 | ($8.2K) | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | ($79.4K) | Sep 28, 2023 |
| FY2023 | Mar 31, 2022 | ($105.3K) | Sep 28, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($231.7K) | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | ($97.4K) | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | ($237.2K) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $226.7K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $153.0K | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $97.1K | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $127.1K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $30.0K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($103.6K) | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | ($341.4K) | Sep 28, 2016 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $30.1K | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $30.6K | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $30.0K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $30.9K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $23.1K | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $33.1K | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $41.7K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $31.3K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $20.0K | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $22.8K | Sep 28, 2016 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $2.04M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $1.81M | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $1.71M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.33M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $1.32M | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $1.42M | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $1.31M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $1.15M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $1.07M | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $1.05M | Sep 28, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($61.3K) | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $145.5K | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | ($383.5K) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $279.5K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $198.8K | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $50.8K | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $86.5K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $199.6K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $18.7K | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | ($392.0K) | Sep 28, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $63.9K | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $180.1K | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $82.6K | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $65.2K | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $23.0K | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $28.8K | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $46.7K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $18.9K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $73.3K | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $66.5K | Sep 28, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $3.20M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $3.56M | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $3.80M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $4.27M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $2.82M | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $2.43M | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $2.36M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $2.73M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $3.12M | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | $2.52M | Sep 28, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $917.1K | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $946.0K | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | $1.13M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | $1.39M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | $657.9K | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | $375.9K | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | $326.5K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $442.3K | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | $848.6K | Oct 12, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $2.29M | Oct 25, 2024 |
| FY2024 | Mar 31, 2024 | $2.25M | Oct 25, 2024 |
| FY2024 | Dec 31, 2023 | $2.35M | Oct 25, 2024 |
| FY2024 | Sep 30, 2023 | $2.59M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | $2.62M | Oct 25, 2024 |
| FY2024 | Mar 31, 2023 | $2.61M | Oct 25, 2024 |
| FY2024 | Dec 31, 2022 | $2.64M | Oct 25, 2024 |
| FY2024 | Sep 30, 2022 | $2.66M | Oct 25, 2024 |
| FY2024 | Jun 30, 2022 | $2.67M | Oct 25, 2024 |
| FY2023 | Mar 31, 2022 | $2.75M | Sep 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | ($2.33M) | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | ($1.99M) | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | ($1.94M) | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | ($1.73M) | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | ($2.42M) | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | ($2.53M) | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | ($2.56M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | ($2.30M) | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | ($2.31M) | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | ($2.42M) | Sep 28, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jun 30, 2019 | $290.3K | Sep 30, 2019 |
| FY2019 | Jun 30, 2018 | $270.3K | Sep 30, 2019 |
| FY2019 | Jun 30, 2017 | $173.2K | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $59.2K | Sep 27, 2018 |
| FY2017 | Jun 30, 2015 | $204.2K | Oct 12, 2017 |
| FY2016 | Jun 30, 2014 | $582.8K | Sep 28, 2016 |
| FY2015 | Jun 30, 2013 | $772.7K | Sep 28, 2015 |
| FY2014 | Jun 30, 2012 | $907.1K | Sep 29, 2014 |
| FY2013 | Jun 30, 2011 | $721.1K | Sep 30, 2013 |
| FY2012 | Jun 30, 2010 | $827.5K | Sep 28, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 0 | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | 0 | Sep 28, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 0 | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | 0 | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | 0 | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 0 | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | 0 | Sep 28, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | 8.12M | Oct 25, 2024 |
| FY2024 | Jun 30, 2023 | 8.09M | Oct 25, 2024 |
| FY2023 | Jun 30, 2022 | 8.09M | Sep 28, 2023 |
| FY2022 | Jun 30, 2021 | 8.09M | Sep 28, 2022 |
| FY2021 | Jun 30, 2020 | 8.09M | Nov 12, 2021 |
| FY2020 | Jun 30, 2019 | 8.09M | Oct 6, 2020 |
| FY2019 | Jun 30, 2018 | 8.08M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 8.08M | Sep 27, 2018 |
| FY2017 | Jun 30, 2016 | 8.06M | Oct 12, 2017 |
| FY2016 | Jun 30, 2015 | 8.06M | Sep 28, 2016 |